Astellas Pharma Inc. (TSE:4503) is seeking acquisitions. Yoshihiko Hatanaka, Chief Executive Officer, President and Representative Director of Astellas Pharma, said, “To accelerate our growth in the future, (inaudible) will bolster strategically allocated and we will actively acquire strategically fit external resources.”